![An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough | European Respiratory Society An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough | European Respiratory Society](https://openres.ersjournals.com/content/erjor/7/3/00447-2021/F1.large.jpg)
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough | European Respiratory Society
![Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/65992c47-b6f6-45ee-ae8d-d5dfae0497c8/gr2.gif)
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine
![Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram](https://www.researchgate.net/profile/Wendy-Komocsar/publication/265174624/figure/fig1/AS:267323823095810@1440746374062/Randomized-controlled-trial-and-open-label-extension-study-designs-aNonresponders-20.png)
Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram
![Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection | American Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection | American](https://jasn.asnjournals.org/content/jnephrol/31/11/2678/F1.large.jpg)
Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection | American
![PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/814ad6ccbfa9defca4d2b00c4672f9070cf6b8da/16-Figure1-1.png)
PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar
![Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial | Scientific Reports Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-81502-2/MediaObjects/41598_2021_81502_Fig1_HTML.png)
Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial | Scientific Reports
![An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1857-3/MediaObjects/13075_2019_1857_Fig1_HTML.png)
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
![An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13601-017-0172-9/MediaObjects/13601_2017_172_Fig1_HTML.gif)
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension | Clinical and Translational Allergy | Full
![Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/06/clinicaltrials-2-e1566478031946.jpg)
Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals
![Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK546770/bin/clapp7f1.jpg)
Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf
![Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study – JCAD | The Journal of Clinical Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study – JCAD | The Journal of Clinical](https://jcadonline.com/wp-content/uploads/PariserNovember2019Fig1.jpg)
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study – JCAD | The Journal of Clinical
![Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram](https://www.researchgate.net/profile/Herbert-Baraf/publication/233396586/figure/fig4/AS:289187577253918@1445959099647/Figure1-Study-design-schematic-for-the-open-label-extension-study-AE-adverse-event-IR.png)